We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




High Blood Glucose Levels Linked to Dementia

By LabMedica International staff writers
Posted on 22 Aug 2013
Adults with a high blood sugar level may have an increased risk of developing dementia compared with those who have a normal blood sugar level. More...


With the aging of the population, dementia has become a major threat to public health worldwide, while the rate of obesity is also increasing, with a parallel increase in the rate of diabetes.

Scientists at the University of Washington School of Medicine (Seattle, WA, USA) analyzed various variables of 2,067 participants without dementia aged 65 and over. In order to examine the relationship between glucose levels and the risk of dementia, they analyzed the median measurements of glycated hemoglobin levels (HbA1C) and glucose levels over a period of 6.8 years.

The results of the study revealed that in the participants with diabetes, the risk of dementia was 40% higher for those with an average glucose level of 190 mg/dL, compared with participants who had an average glucose level of 160 mg/dL. The results also showed that in the participants without diabetes, the risk of dementia was 18% higher for those with an average glucose level of 115 mg/dL versus those with an average of 100 mg/dL.

The investigators said that including both glucose levels and glycated hemoglobin in the measurements was the key as blood sugar levels rise and fall throughout the day, but glycated hemoglobin does not vary as much over short periods. However, they add that these results do not necessarily mean that people should eat foods with a lower "glycemic index," but exercise may help.

Paul K. Crane, MD, MPH, an associate professor and lead author, said, “The most interesting finding was that every incrementally higher glucose level was associated with a higher risk of dementia in people who did not have diabetes. There was no threshold value for lower glucose values where risk leveled off. Your body turns your food into glucose, so your blood sugar levels depend not only on what you eat but also on your individual metabolism: how your body handles your food."

The authors concluded that although their results show that higher glucose levels are linked to higher dementia risk, there is no data to suggest people who make changes to lower their glucose levels will reduce the risk of dementia. The study was published on August 8, 2013, in the New England Journal of Medicine (NEJM).

Related Links:

University of Washington School of Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
New
Drug Testing Assays
Atellica DT 250 Analyzer
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.